Philadelphia, PANCT04176172Now EnrollingIRB Ready

Nicotine Dependence Clinical Trial in Philadelphia, PA

Access cutting-edge nicotine dependence treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by University of Pennsylvania

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions...

Expert Care in Philadelphia

Access nicotine dependence specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nicotine dependence treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this nicotine dependence clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Nicotine Dependence Study in Philadelphia

The advent of anti-retroviral therapy (ART) for people living with HIV/AIDS (PLWHA) substantially improved life expectancy but has also led to the critical need to address modifiable risk factors associated with cancer and cardiovascular disease, such as tobacco smoking. HIV-infected smokers lose more life-years due to tobacco use than they do to their HIV infection. There have been relatively few studies of tobacco use treatments for PLWHA and systematic reviews show that there are insufficien

Sponsor: University of Pennsylvania

Who Can Participate

Inclusion Criteria

\>18 years, smoke daily for the past 30 days
Confirmed HIV+ (exhibit viral load of \<1000 copies/mL)
Residing in the geographic area close to one of the sites for at least 7 months
Able to use varenicline/TN patch safely Key

Exclusion Criteria

Current untreated and unstable diagnosis of substance abuse/dependence
Current diagnosis of unstable and untreated major depression, psychosis or bipolar disorder
Suicide risk as measured by the C-SSRS
Current use or discontinuation within last 14 days of quit smoking medications
Cancer, heart disease, stroke or MI within the past 6 months requires study physician approval
Uncontrolled hypertension
History of epilepsy or seizure disorder requires study physician approval
Women who are pregnant, planning a pregnancy, or lactating
Use of e-cigarettes, chewing tobacco, snuff or snus
Generalized eczema or psoriasis
A reaction or sensitivity to a nicotine patch or any other transdermal medicati

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT04176172) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Nicotine Dependence Treatment Options in Philadelphia, PA

If you're searching for nicotine dependence treatment options in Philadelphia, PA, this clinical trial (NCT04176172) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nicotine dependence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all nicotine dependence clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Philadelphia, PA

See all pulmonary embolism clinical trials recruiting in Philadelphia โ€” not just this study.

Browse Pulmonary Embolism Trials in Philadelphia โ†’

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure ยท Expert Care ยท Philadelphia, PA